dr. blackwell discusses margetuximab for her2 breast cancer
Published 8 years ago • 407 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:39
dr. blackwell on treatment landscape of her2 breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
1:43
dr. blackwell discusses the her2climb study in her2 breast cancer
-
1:15
dr. blackwell on the impact of the cleopatra and marianne studies in her2 breast cancer
-
0:46
dr. kimberly l. blackwell on a promising her2 breast cancer treatment
-
1:44
dr. blackwell on neratinib in her2 breast cancer
-
1:31
dr. pegram on margetuximab plus chemo in her2 breast cancer
-
1:09
dr. blackwell on late recurrences in patients with breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
1:50
dr. kimberly blackwell discusses the t-dm1 emilia trial
-
4:05
sophia trial in r/r her2 mbc
-
1:04
dr. kimberly blackwell discusses the t-dm1 emilia trial coprimary endpoints
-
0:52
dr. blackwell on emerging therapies in tnbc
-
1:39
dr. rugo on the impact of margetuximab based on cd16a fc receptors in her2 breast cancer
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
0:41
dr. freedman discusses dual her2-targeted therapy in breast cancer
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:21
dr. louis weiner discusses the t-dm1 emilia trial for her2-positive breast cancer